Creabilis Therapeutics' Series B Round

Creabilis Therapeutics raised a round of funding on October 04, 2011.

Creabilis is a privately-held specialty pharmaceutical company focused on developing first-in-class topical treatments for common inflammatory skin conditions, including psoriasis, atopic dermatitis, …

Articles about Creabilis Therapeutics' Series B Round: